๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

2 Hepatitis C virus (HCV) recurrence is an early and severe event in living donor liver transplantation (LDLT)

โœ Scribed by M. Garcia-Retortillo; X. Forms; J.M. Llovet; M. Navasa; A. Massaguer; A. Feliu; M. Bruguera; J. Fuster; J.C. Garcia-Valdecasas; A. Rimola

Book ID
117372832
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
59 KB
Volume
40
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hepatitis C recurrence is more severe af
Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation
โœ Montserrat Garcia-Retortillo; Xavier Forns; Josep M. Llovet; Miquel Navasa; Anna ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 197 KB ๐Ÿ‘ 1 views

Preliminary reports suggested that hepatitis C virus (HCV) infection has a more aggressive course following living donor liver transplantation (LDLT) compared to cadaveric liver transplantation (CLT). The aim of this prospective study was to establish if HCV disease recurrence differs between LDLT a

Histologic recurrence of chronic hepatit
Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation
โœ Mitchell L. Shiffman; R. Todd Stravitz; Melissa J. Contos; A. Scott Mills; Richa ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB ๐Ÿ‘ 2 views

Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We

Hepatic steatosis at 1 year is an additi
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus
โœ Danielle Brandman; Andrea Pingitore; Jennifer C. Lai; John P. Roberts; Linda Fer ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 2 views

Recurrent hepatitis C virus (HCV) is the most common cause of graft loss for HCV-infected recipients of liver transplantation (LT). Diabetes mellitus (DM) has been associated with increased rates of fibrosis progression, but whether steatosis affects post-LT outcomes independently of DM is unclear.